STOCK TITAN
  1. Home
  2. Financials
  3. BRNS
  4. EPS (Diluted)

Barinthus Biotherapeutics plc American (BRNS) EPS by Year

BRNS

Barinthus Biotherapeutics plc American lost $1.64 per diluted share in fiscal year 2025. This represents a decrease of 5.8% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a loss of $1.03 per diluted share. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Barinthus Biotherapeutics plc American has filed alongside them.

FY2025 annual
EPS (Diluted) -$1.64
YoY -5.8%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

BRNS EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-K
EPS (Diluted)-$1.03-$1.64-5.8%-$1.55+18.8%-$1.91-1464.3%$0.14+107.1%-$1.96-$2.24

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

BRNS EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
EPS (Diluted)-$0.26+50.0%-$0.14+71.4%-$0.27+47.1%-$0.36-71.4%-$0.52-20.9%-$0.49-22.5%-$0.51-13.3%-$0.21+43.2%-$0.43+30.6%-$0.40+16.7%-$0.45+18.2%-$0.37-268.2%

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More Barinthus Biotherapeutics plc American financials

Frequently Asked Questions

What was Barinthus Biotherapeutics plc American's diluted earnings per share in fiscal year 2025?

Barinthus Biotherapeutics plc American lost $1.64 per diluted share in fiscal year 2025.

How fast is Barinthus Biotherapeutics plc American's diluted earnings per share growing?

Barinthus Biotherapeutics plc American (BRNS) diluted earnings per share fell by 5.8% year over year, from -$1.55 to -$1.64 in fiscal year 2025.

What is Barinthus Biotherapeutics plc American's diluted earnings per share over the last twelve months?

Barinthus Biotherapeutics plc American (BRNS) reported a loss of $1.03 per diluted share over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 6 fiscal years this page covers, Barinthus Biotherapeutics plc American (BRNS) diluted earnings per share went from -$2.24 in fiscal year 2020 to -$1.64 in fiscal year 2025.

Barinthus Biotherapeutics plc American (BRNS) reported -$0.26 in diluted earnings per share in Q2 2026. This represents an increase of 50.0% from the same quarter a year earlier.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Barinthus Biotherapeutics plc American (BRNS) reported on that line in every period on record.